Ocular Rosacea Biome Study

NCT05296837 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Ocular Rosacea
Antimicrobial Resistance

Interventions

DRUG: Doxycycline 40 MG ( 20mg twice daily)
DRUG: Doxycycline 200 MG ( 100 mg twice daily)
DRUG: Placebo

Sponsor

University of California, San Francisco